Project Grant T32TR006156
- The University of Pennsylvania received a $532,701 Project Grant award from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) on July 6, 2026, to establish and operate a Clinical and Translational Science (CTS) Postdoctoral T32 Training Program. The program supports annual training of five postdoctoral fellows—two with PhDs and three clinicians—for 1–2 year periods through May 31, 2031. Trainees engage in mentored research projects embedded within an academic...
- Federal Grant Award Summary New York University School of Medicine received a $462,079 Project Grant from the National Center for Advancing Translational Sciences (NCATS) (CFDA 93.350) awarded September 1, 2026, through August 31, 2031. The NYU Clinical and Translational Science Institute (CTSI) T32 Postdoctoral Training Program directly supports NCATS' mission to accelerate the translation of scientific discoveries into improved healthcare outcomes by developing the next generation of...
- Award Summary The University of Pennsylvania received a $10.8 million Cooperative Agreement from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) effective July 1, 2026, through May 31, 2033, to establish and operate the Penn-CHOP Clinical and Translational Science Award (CTSA) Hub. The hub will deliver integrated clinical and translational science services across four primary domains: developing and disseminating novel translational therapeutics; applying advanced...
- Federal Grant Award Summary The University of Florida received a $294,186 Project Grant award from the National Center for Advancing Translational Sciences (NCATS), CFDA 93.350, effective August 20, 2025, through June 30, 2030. This award supports the CTSA (Clinical and Translational Science Award) Predoctoral T32 training program, which develops and implements a specialized clinical and translational science team training curriculum for paired PhD and combined-degree (MD-PhD) predoctoral...
- Federal Grant Award Summary The University of Pennsylvania received a $812,500 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on September 15, 2025, with completion targeted for August 31, 2030. This research initiative will develop statistical methods and computational tools to advance polygenic risk score (PRS) prediction and discovery of disease-causal gene pathways. The project...
- Federal Grant Award Summary The Johns Hopkins University received a $1,095,342 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded September 15, 2025, with a completion date of August 31, 2030. The award funds the Clinical and Translational Science Award (CTSA) Postdoctoral T32 Training Program at Johns Hopkins University's Institute for Clinical and Translational Research (ICTR). The program provides integrated postdoctoral training in...
- Federal Project Grant Award Summary The University of Pennsylvania received a $1,204,698 Project Grant from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded July 1, 2025, through June 30, 2027, to advance trial readiness for LCAT deficiency, an ultra-rare autosomal recessive genetic condition. The project focuses on identifying and validating biomarkers to support clinical development of emerging therapeutics, including gene therapy approaches for this...
- Federal Grant Award Summary The University of Pennsylvania received an $887,612 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through June 30, 2030. This award funds fundamental research investigating the coordination and coregulation of enzyme-mediated chemical modifications across distinct ribonucleic acid (RNA) species, specifically examining mRNA, tRNA...
- Federal Grant Award Summary The National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) awarded The Trustees of Columbia University in the City of New York a $275,316 Project Grant effective July 1, 2026, through May 31, 2031, to support the Irving Institute for Clinical and Translational Research's predoctoral T32 training program. This award funds the continuation of a approximately 20-year legacy of training predoctoral fellows in clinical and translational research, with...
- Federal Grant Award Summary The Ohio State University's Office of Sponsored Programs received a $252,545 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, effective September 17, 2025 through July 31, 2030. The award supports the establishment of a Clinical and Translational Data Science (CTDS) T32 postdoctoral training program administered by the Ohio State University Clinical and Translational Science Institute. The program delivers...
The University of Pennsylvania received a $553,631 Project Grant award from the National Center for Advancing Translational Sciences (NCATS) under CFDA 93.350, effective July 6, 2026, through May 31, 2031. The CTSA (Clinical and Translational Science Award) Predoctoral T32 program provides comprehensive training and mentorship to 10 predoctoral trainees at any given time, drawn from PhD, MD (Doctor of Medicine), DMD (Doctor of Dental Medicine), and VMD (Doctor of Veterinary Medicine) students, with appointments lasting 1-3 years depending on career stage and program. The program delivers three core services: (1) rigorous clinical and translational science investigator training through immersive mentored research experiences, proven mentoring constructs, core knowledge acquisition, and modular education in emerging areas; (2) career preparation and transition support through personalized career mapping, professional development activities, and individualized transition assistance; and (3) a supportive training environment that sustains long-term engagement in clinical and translational science. The training program leverages the University of Pennsylvania's unique institutional ecosystem, including its historical role as the birthplace of mRNA therapeutics and cell/gene therapies, to address gaps in traditional graduate education by exposing students to clinical and translational science concepts and methodological domains. By providing this specialized predoctoral training pipeline, the award supports development of the next generation of clinical and translational science investigators capable of efficiently translating research discoveries into clinical practice for academic, industry, nonprofit, and government career pathways.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $553.6k | 7/7/26 |